Patents Issued in March 1, 2022
-
Patent number: 11260197Abstract: A respiratory treatment device for the combined administration of respiratory muscle training (“RMT”) and oscillating positive expiratory pressure (“OPEP”) therapy, and administration of RMT using pressure threshold resistors and flow resistors with respiratory treatment devices, such as OPEP devices.Type: GrantFiled: July 10, 2019Date of Patent: March 1, 2022Assignee: Trudell Medical InternationalInventors: Adam Meyer, Dan Engelbreth
-
Patent number: 11260198Abstract: Systems and methods of assisting a subject to reach a target state include obtaining input of the target state of the subject; and generating a transcutaneous vibratory output to be applied to a portion of a body of the subject to assist the subject in achieving the target state, the transcutaneous vibratory output having variable parameters comprising a perceived pitch, a perceived beat, and a perceived intensity wherein the step of generating the transcutaneous vibratory output further comprises the step of modifying the variable parameters to correspond to the target state.Type: GrantFiled: December 20, 2019Date of Patent: March 1, 2022Assignee: Apollo Neuroscience, Inc.Inventors: David Mayer Lowell Rabin, Kathryn Fantauzzi, Raymond G. Pelletier
-
Patent number: 11260199Abstract: Disclosed is a weighted material that is configured to effectuate deep pressure therapy to a person when the weighted material is used as a blanket over the person's body. A length of layered yarn is interlooped to form the weighted material. The layered yarn includes an outer tube extending longitudinally from a first end to a second end. The outer tube defines a conduit extending longitudinally therethrough from the first end to the second end. A fiber material is disposed within the conduit and extend longitudinally from the first end to the second end. The interlooped length of yarn, by itself, is configured and sufficiently weighted to effectuate deep pressure therapy to a person when the blanket lies over the person's body. Various other systems and methods are also disclosed.Type: GrantFiled: November 16, 2020Date of Patent: March 1, 2022Assignee: Bearaby Inc.Inventor: Kathrin Hamm
-
Patent number: 11260200Abstract: Apparatus and methods are provided for making catheters having relatively larger distal and proximal regions and/or including intermediate layers that minimize or eliminate gaps during manufacturing, and to catheters or other tubular devices made using such apparatus and methods.Type: GrantFiled: September 16, 2018Date of Patent: March 1, 2022Inventors: Christian S. Eversull, Stephen A. Leefleng
-
Patent number: 11260201Abstract: Systems and methods are disclosed herein that generally involve CED devices with various features for reducing or preventing backflow. In some embodiments, CED devices include a tissue-receiving space disposed proximal to a distal fluid outlet. Tissue can be compressed into or pinched/pinned by the tissue-receiving space as the device is inserted into a target region of a patient, thereby forming a seal that reduces or prevents proximal backflow of fluid ejected from the outlet beyond the tissue-receiving space. In some embodiments, CED devices include a bullet-shaped nose proximal to a distal fluid outlet. The bullet-shaped nose forms a good seal with surrounding tissue and helps reduce or prevent backflow of infused fluid.Type: GrantFiled: August 31, 2018Date of Patent: March 1, 2022Assignee: ALCYONE LIFESCIENCES, INC.Inventors: Deep Arjun Singh, Pj Anand, Blake Sama
-
Patent number: 11260202Abstract: Provided is an apparatus for injecting a lipolysis composition, the apparatus including a lipolysis composition storage, a pump, and at least one nozzle-type needle.Type: GrantFiled: May 16, 2019Date of Patent: March 1, 2022Inventor: Seung Min Yoo
-
Patent number: 11260203Abstract: An anchor device to simplify catheterization procedures, particularly for insertion and maneuvering of large catheters in tortuous arteries, vessels, or other lumen is disclosed. In some embodiments, the anchor device includes an anchor stent formed from a plurality of zig-zag shaped wire elements that are coupled together. The device further includes a plurality of connector struts attached at a proximal end of the anchor stent, the connector struts coalescing to form a strut tip. A guide device, such as a guidewire, is attached to the anchor stent at the strut tip and may be used to guide the anchor stent into the arteries or other vessels and toward a target treatment site.Type: GrantFiled: June 17, 2019Date of Patent: March 1, 2022Assignee: ANCHOR ENDOVASCULAR, INC.Inventor: George P. Teitelbaum
-
Patent number: 11260204Abstract: A safety catheter insertion device configured to automatically retract a needle cannula following insertion of a catheter assembly and to inhibit release of the catheter assembly from the safety catheter insertion device until the needle cannula has been retracted for the purpose of inhibiting inadvertent needle sticks. The safety catheter insertion device including an advancement arm slidably coupled to a needle housing assembly and configured to shift between a first position in which a needle cannula traverses through a catheter hub coupling portion of the advancement arm to inhibit release of a catheter assembly, and a second position in which one or more tabs of the advancement arm interact with one or more retention arms of the needle housing assembly to enable a biasing mechanism to shift the needle assembly to a proximal position and enable release of the catheter assembly from the safety catheter insertion device.Type: GrantFiled: April 9, 2019Date of Patent: March 1, 2022Assignee: Smiths Medical ASD, Inc.Inventors: Daniel Casey Johnson, Eric Jason Krause, David J. Goral, Jay T. Breindel, Tye Jensen, Marco Monti
-
Patent number: 11260205Abstract: A guide wire including a flexible first core wire which has a first plate-shaped portion having a plate shape and a first linear portion having a linear shape that is continuous to the first-plate shaped portion. The width of the first plate-shaped is larger than the width of the first linear portion. The guide wire includes a flexible second core wire which has a second plate-shaped portion having a plate shape and a second linear portion having a linear shape that is continuous to the second-plate shaped portion. The width of the second plate-shaped portion is larger than the width of the second linear portion. The second plate-shaped portion axially overlaps the first linear portion, and the second linear portion axially overlaps the first plate-shaped portion.Type: GrantFiled: October 9, 2018Date of Patent: March 1, 2022Assignee: TERUMO KABUSHIKI KAISHAInventor: Shuhei Inoue
-
Patent number: 11260206Abstract: A device for one-handed insertion of a guidewire into a vessel or cavity is provided. The device has a body, an actuator carriage, a guidewire feed, and a syringe. The body has a handle, a guideway, and a clip to retain the syringe. The syringe has a barrel and a plunger with a flange and a guidewire passage. The actuator carriage has a trigger and a clip to grasp the syringe plunger flange. The actuator carriage slides along the body guideway. The guidewire feed has a wire feed surface. The thumb engages wire at the wire feed surface to advance and retract the wire through the guidewire passage and a finger moves the trigger to move the syringe plunger rearwardly and/or forwardly, while the remaining fingers of the one hand grasp the handle. The device allows the user to sense resistance encountered by the tip of the wire.Type: GrantFiled: November 10, 2017Date of Patent: March 1, 2022Assignee: EVA INNOVATIONS, INC.Inventors: Daniel B. Stone, Jeffrey A. Panozzo
-
Patent number: 11260207Abstract: The present invention relates to a catheter valve for use with a catheter. The catheter valve comprises an inlet nozzle at a front end of the valve and an outlet nozzle at a rear end of the valve. The valve comprises a longitudinal stem encapsulated within a middle section of the valve which extends in between the front end and the rear end of the valve.Type: GrantFiled: May 16, 2018Date of Patent: March 1, 2022Inventor: Kim Seng Chong
-
Patent number: 11260208Abstract: An apparatus includes a shaft, an expandable dilation member, and a bulbous tip. The shaft has a first outer cross-sectional dimension. The dilation member is positioned proximal to the distal end of the shaft. The dilation member is operable to transition between a non-expanded configuration and an expanded configuration. The dilation member is sized to pass through a passageway associated with drainage of a paranasal sinus or a Eustachian tube when the dilation member is in the non-expanded configuration. The bulbous tip is positioned at the distal end of the shaft. The bulbous tip is distal to the dilation member. The bulbous tip has a second outer cross-sectional dimension. The second outer cross-sectional dimension is larger than the first outer cross-sectional dimension. The bulbous tip is removably secured to the distal end of the shaft.Type: GrantFiled: June 8, 2018Date of Patent: March 1, 2022Assignee: Acclarent, Inc.Inventors: Jetmir Palushi, Azhang Hamlekhan, John H. Thinnes, Jr.
-
Patent number: 11260209Abstract: A microneedling machine for tattooing is disclosed, which has a substantially radially symmetric exterior shape and may include subcomponents that can be disassembled and sterilized. The machine may include an adjustment mechanism for configuring the impact of the microneedle into skin. The machine may also include a motion translation device adapted to change rotational motion of the drive shaft or motor into linear reciprocating motion of the microneedle.Type: GrantFiled: August 29, 2018Date of Patent: March 1, 2022Assignee: FK Irons Inc.Inventor: Gaston Siciliano
-
Patent number: 11260210Abstract: An exemplary ultraviolet (UV) arrangement, can be provided, which can include, for example, a lumen structured to be inserted into a body of a patient and pass a percutaneous structure therethrough into the body of the patient, wherein the lumen can be configured to disperse or provide a UV radiation, and an optical arrangement coupled to the lumen, and configured to generate the UV radiation, and provide the UV radiation to the lumen to be dispersed or provided by the lumen. The lumen can include a weave of a plurality of strands. The optical arrangement can include an optical fiber(s) coupled to the lumen at one of the strands. The optical arrangement can include a plurality of optical fibers coupled to the lumen, where the optical arrangement can include a plurality of diffusing rings, and wherein each ring can be connected to one of the optical fibers.Type: GrantFiled: May 16, 2016Date of Patent: March 1, 2022Assignee: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORKInventors: Henry Spotnitz, David J. Brenner, Alan Bigelow, Gerhard Randers-Pehrson
-
Patent number: 11260211Abstract: A variable volume infusion port is provided. The infusion port may include a port body having an internal fluid reservoir, a septum, a stem to fluidly couple to a catheter lumen, and a displaceable member disposed in the internal fluid reservoir. In a first position, the displaceable member is disposed proximate the septum, providing a relatively small fluid volume within the infusion port. Insertion of an injection device through the septum causes the displaceable member to move to a second location distal from the septum, providing a relatively large fluid volume within the infusion port for the duration the injection device remains in the infusion port. The displaceable member may include a rigid member operably coupled to a biasing element or a flexible member coupled to a biasing element.Type: GrantFiled: February 26, 2018Date of Patent: March 1, 2022Assignee: PRIMO MEDICAL GROUP, INC.Inventor: Richard P. Rodgers
-
Patent number: 11260212Abstract: Apparatus and methods are described including a tube configured to traverse a subject's aortic valve. A frame is disposed within a portion of the tube, and an impeller is disposed inside the tube such that, when the impeller and the tube are deployed inside the subject, a gap between an outer edge of the impeller and an inner surface of the tube is less than 1 mm. The impeller rotates such as to pump blood from the left ventricle to the aorta, and is stabilized with respect to the tube, such that, during rotation of the impeller, the gap between the outer edge of the impeller and the inner surface of the tube is maintained. The impeller includes at least one impeller blade defined by a helical elongate element, and a film of material supported by the helical elongate element. Other applications are also described.Type: GrantFiled: February 15, 2019Date of Patent: March 1, 2022Assignee: Magenta Medical Ltd.Inventors: Yosi Tuval, Daniel Glozman, Gad Lubinsky
-
Patent number: 11260213Abstract: An impeller for a pump is disclosed herein. The impeller can include a hub having a fixed end and a free end. The impeller can also have a plurality of blades supported by the hub. Each blade can have a fixed end coupled to the hub and a free end. The impeller can have a stored configuration and a deployed configuration, the blades in the deployed configuration extending away from the hub, and the blades in the stored configuration being compressed against the hub.Type: GrantFiled: October 29, 2020Date of Patent: March 1, 2022Assignee: TC1 LLCInventors: Zijing Zeng, Phyllis Yuen, Michael R. Butler
-
Patent number: 11260215Abstract: The invention relates to a flexible catheter (1) with a drive shaft (2), with a sleeve (6) surrounding the drive shaft (2) and with a sheath (7) surrounding the drive shaft (2) and the sleeve (6), wherein the drive shaft, the sleeve (6) and the sheath (7) are pliable, wherein the drive shaft (2) at a proximal end of the drive shaft (2) comprises a coupling element (5) for connecting the drive shaft (2) to a drive motor (18), wherein the drive shaft (2) at least regionally consist of a alloy which contains at least 10% by weight of chromium, nickel and cobalt in each case. The invention moreover relates to a blood pump arrangement with such a catheter.Type: GrantFiled: October 14, 2019Date of Patent: March 1, 2022Assignee: ECP ENTWICKLUNGSGESELLSCHAFT MBHInventors: Mario Scheckel, Joerg Schumacher
-
Patent number: 11260216Abstract: A ventricularly implantable medical device that includes a sensing module that is configured to detect an artifact during ventricular filling and to identify an atrial event based at least on part on the detected artifact. Control circuitry of the implantable medical device is configured to deliver a ventricular pacing therapy to a patient's heart, wherein the ventricular pacing therapy is time dependent, at least in part, on the identified atrial event.Type: GrantFiled: November 27, 2018Date of Patent: March 1, 2022Assignee: CARDIAC PACEMAKERS, INC.Inventors: Jeffrey E. Stahmann, Keith R. Maile, Krzysztof Z. Siejko, Allan Charles Shuros, William J. Linder, Benjamin J. Haasl, Michael J. Kane, Brendan Early Koop
-
Patent number: 11260217Abstract: A mask-type beauty instrument includes a flexible mask and a controller. The flexible mask includes a first flexible layer, a second flexible layer, a plurality of functional layers located between the first flexible layer and the second flexible layer, and a plurality of electrodes electrically connected with the plurality of functional layers. The functional layer includes a carbon nanotube layer including a plurality of carbon nanotubes uniformly distributed. The flexible mask is electrically coupled with the controller via the plurality of electrodes.Type: GrantFiled: September 29, 2020Date of Patent: March 1, 2022Assignee: Beijing FUNATE Innovation Technology Co., LTD.Inventors: Li Fan, Li Qian, Yu-Quan Wang
-
Patent number: 11260218Abstract: A garment worn by the patient is provided. The garment has a first module electrically connected to a second module. The first module has a first sub-control unit electrically connected to a first electrode and a second electrode placed at a first muscle and a third electrode and a fourth electrode placed at a second muscle. The sub-control unit is electrically connected to a master unit. The first muscle is stimulated with a first stimulation signal without shortening the first muscle by sending the first stimulation signal to the first electrode placed. The stimulation of the first muscle relaxes the second muscle.Type: GrantFiled: November 11, 2019Date of Patent: March 1, 2022Assignee: EXONEURAL NETWORK ABInventors: Lars Dernebo, Fredrik Lundqvist
-
Patent number: 11260219Abstract: An exemplary sound processor included in a cochlear implant system may include a control facility that represents a first frequency domain signal to a patient by 1) directing a cochlear implant included in the cochlear implant system to apply, during a first stimulation frame, a first monophasic stimulation pulse representative of a first temporal portion of the first frequency domain signal that corresponds to the first stimulation frame, the first monophasic stimulation pulse having a first polarity, and 2) directing the cochlear implant to apply, during a second stimulation frame that is temporally subsequent to the first stimulation frame, a second monophasic stimulation pulse representative of a second temporal portion of the first frequency domain signal that corresponds to the second stimulation frame, the second monophasic stimulation pulse configured to at least partially charge balance the first monophasic stimulation pulse and having a second polarity opposite the first polarity.Type: GrantFiled: October 9, 2019Date of Patent: March 1, 2022Assignee: Advanced Bionics AGInventor: R. Tissa Karunasiri
-
Patent number: 11260220Abstract: Cochlear implant systems can include a signal processor, an implantable battery and/or communication module, and a plurality of conductors coupling the implantable battery and/or communication module and the signal processor. The implantable battery and/or communication module can communicate data and deliver electrical power to the signal processor via the plurality of conductors. The implantable battery and/or communication module can be configured to perform characterization process to determine one or more characteristics of one or more such conductors. Characterization processes can include determining an impedance between two conductors as a function of frequency, determining whether a conductor is intact, and determining an impedance of a given conductor. Some characterization processes include grounding one or more conductors.Type: GrantFiled: February 21, 2020Date of Patent: March 1, 2022Assignee: Envoy Medical CorporationInventors: Paul R. Mazanec, Joshua J. Wibben, Timothy J. Earnest
-
Patent number: 11260221Abstract: The present disclosure relates to implantable neuromodulation devices and methods of fabrication, and in particular to a thin-film electrode assemblies and methods of fabricating the thin-film electrode assembly to include a soft overmold. Particularly, aspects of the present invention are directed to a thin-film electrode assembly that includes an overmold and a supporting structure formed within a portion of the overmold. The overmold includes a first polymer and the supporting structure includes a second polymer, different from the first polymer. The thin-film electrode assembly also includes a wire formed within a portion of the supporting structure, and an electrode formed on a top surface of the supporting structure and in electrical contact with the wire.Type: GrantFiled: October 1, 2019Date of Patent: March 1, 2022Assignee: Verily Life Sciences LLCInventors: Brian Pepin, Shiv Sabesan, Bo Lu
-
Patent number: 11260222Abstract: Radiopaque markers represent that a lead is suitable for a particular medical procedure such as a magnetic resonance image scan and are added to the lead or related device. The markers may be added after implantation of the lead in various ways including suturing, gluing, crimping, or clamping a radiopaque tag to the lead or to the device. The markers may be added by placing a radiopaque coil about the lead, and the radiopaque coil may radially contract against the lead to obtain a fixed position. The markers may be added by placing a polymer structure onto the lead where the polymer structure includes a radiopaque marker within it. The polymer structure may include a cylindrical aperture that contracts against the lead to fix the position of the polymer structure. The polymer structure may form a lead anchor that includes suture wings that can be sutured to the lead.Type: GrantFiled: December 19, 2019Date of Patent: March 1, 2022Assignee: MEDTRONIC, INC.Inventors: James M. Olsen, Michael R. Klardie, Richard T. Stone, Chad Q. Cai, Spencer Fodness-Bondhus, Mark J. Conroy, Timothy R. Abraham, Bruce R. Mehdizadeh, Michael J. Kern, Jay K. Lahti
-
Patent number: 11260223Abstract: A low-frequency treatment device and a treatment system with enhanced user convenience. An acquisition unit acquires an atmospheric pressure of a position where the low-frequency treatment device is located (step S102), a determination unit determines whether the atmospheric pressure is less than a threshold (step S104), and a treatment portion increases an intensity of low frequency treatment if the atmospheric pressure is less than the threshold (step S108).Type: GrantFiled: January 29, 2020Date of Patent: March 1, 2022Assignee: OMRON HEALTHCARE CO., LTD.Inventors: Mitsuru Samejima, Yui Watanabe
-
Patent number: 11260224Abstract: The invention comprises a method and apparatus for delivering electrons to skin of a person, comprising the steps of: (1) attaching a longitudinal length of a flexible electrically conductive tape to the skin of the person, the flexible electrically conductive tape comprising: an electrically conductive strip and an adhesive layer, the adhesive layer comprising a top surface and an adhesive surface, (2) the adhesive surface affixing the electrically conductive strip to the skin, where the adhesive layer comprises a set of apertures therethrough to form longitudinally distributed electrical contact points along a length of the electrically conductive strip; and (3) an energy source delivering electrons, under control of an electrical control circuit of a controller, to the electrical contact points of the flexible electrically conductive tape.Type: GrantFiled: November 15, 2019Date of Patent: March 1, 2022Inventor: Traci Schmidt
-
Patent number: 11260225Abstract: Devices, systems and methods are disclosed that allow a patient to self-treat a medical condition, such as migraine headache, by electrical non-invasive stimulation of a nerve, such as the vagus nerve. A nerve stimulator is configured for coupling to a mobile device configured to receive a wireless signal, such as a mobile phone. The stimulator is further configured to generate an electrical impulse and to transmit the electrical impulse through the contact surface and the outer skin surface of the patient to modulate a nerve within the patient.Type: GrantFiled: May 10, 2021Date of Patent: March 1, 2022Assignee: ELECTROCORE, INCInventors: Joseph P. Errico, Steven Mendez, Bruce J. Simon
-
Patent number: 11260226Abstract: An exemplary cochlear implant assembly includes a cochlear implant configured to apply electrical stimulation to the recipient by way of an electrode array, a cochlear implant antenna communicatively coupled to the cochlear implant, and an encapsulant that covers the cochlear implant and the cochlear implant antenna, the encapsulant impregnated with a dielectric material that is configured to confine an electric field around the cochlear implant antenna. Corresponding methods for manufacturing cochlear implant assemblies are also described.Type: GrantFiled: August 16, 2019Date of Patent: March 1, 2022Assignee: Advanced Bionics AGInventors: Glen A. Griffith, Jeryle L. Walter
-
Patent number: 11260227Abstract: A method of calibrating stimulation threshold levels of a cochlear implant, comprises sending a series of stimulation signals having a predetermined length in time to a selected subset of a plurality of stimulation electrodes of the cochlear implant of a user, wherein for each signal of the series of stimulation signals, the stimulation level is larger compared to the stimulation level of the previous stimulation signal; receiving an electrophysiological signal for each stimulation signal from a measurement electrode attached to the head of the user; calculating a cross-correlation signal for each of the received electrophysiological signals for each stimulation level following the first stimulation signal with respect to the first electrophysiological signal received for the first stimulation signal, determining, whether the respective cross-correlation signal exceeds a predetermined threshold level, wherein the sending of the series of stimulation signals is stopped and the stimulation level is set as the tType: GrantFiled: October 16, 2019Date of Patent: March 1, 2022Assignee: OTICON MEDICAL A/SInventors: Pierre Stahl, Dan Gnansia
-
Patent number: 11260228Abstract: A wearable device combines its existing functions (e.g., a headphone) with non-invasive autonomic modulation using tragus or other external auditory meatus stimulation. The wearable device can output audio to a user, such as music, podcast, etc., and further provide modulation of the vagus nerve via tragus stimulation or other external auditory meatus stimulation to treat various diseases.Type: GrantFiled: May 20, 2020Date of Patent: March 1, 2022Assignee: Mayo Foundation for Medical Education and ResearchInventor: Samuel J. Asirvatham
-
Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
Patent number: 11260229Abstract: Disclosed are apparatuses and methods for reducing or limiting blood loss and reducing bleed time in a subject by combined vagus and trigeminal stimulation. The apparatuses and methods may activate (e.g., electrically) one or more branches of the trigeminal nerve and may concurrently (at overlapping or near-overlapping time) independently activate the vagus nerve. This activation may be invasive or non-invasive.Type: GrantFiled: September 25, 2019Date of Patent: March 1, 2022Assignee: The Feinstein Institutes for Medical ResearchInventor: Kirk R. Manogue -
Patent number: 11260230Abstract: An implantable pulse generator (IPG) that generates spinal cord stimulation signals for a human body has a programmable signal generator that can generate the signals based on stored signal parameters without any intervention from a processor that controls the overall operation of the IPG. While the signal generator is generating the signals the processor can be in a standby mode to substantially save battery power. The IPG also contains circuity to indicate to a patient that proper alignment exists between the IPG and an external charger to charge a battery in the IPG.Type: GrantFiled: September 17, 2019Date of Patent: March 1, 2022Assignee: Cirtec Medical CorporationInventors: Saif Khalil, Raghavendra Angara, Miles Curtis, Christopher Biele, Daniel Fellmeth, Hrishikesh Gadagkar
-
Patent number: 11260231Abstract: Techniques, systems, and devices are disclosed for delivering stimulation therapy to a patient. In one example, a medical device determines a first set of stimulation parameters that define entrainment stimulation pulses configured to entrain electrical activity in a patient. The medical device may control a stimulation generator to generate the entrainment stimulation pulses according to the first set of stimulation parameters. The medical device may further determine a second set of stimulation parameters that define at least one desynchronization stimulation pulse configured to disrupt at least a portion of the electrical activity entrained by the entrainment stimulation pulses. The medical device may subsequently control the stimulation generator to generate the desynchronization stimulation pulse(s) according to the second set of stimulation parameters.Type: GrantFiled: January 24, 2020Date of Patent: March 1, 2022Assignee: Medtronic, Inc.Inventors: Rene A. Molina, Robert S. Raike, Scott R. Stanslaski
-
Patent number: 11260232Abstract: Feedback regarding electrical stimulation is provided to a patient. Electrical stimulation is applied to the patient. The electrical stimulation is applied by varying an electrical stimulation parameter. A signal is communicated to the patient via an electronic device. The signal is correlated with the electrical stimulation parameter such that the signal varies in association with the varying of the electrical stimulation parameter. The communicating is performed while the electrical stimulation is applied. Feedback is received from the patient in response to the electrical stimulation. Based on the received feedback from the patient, the electrical stimulation is adjusted.Type: GrantFiled: October 22, 2018Date of Patent: March 1, 2022Assignee: CIRTEC MEDICAL CORPORATIONInventors: Norbert Kaula, Yohannes Iyassu
-
Patent number: 11260233Abstract: According to some aspects, a cardiac pacemaker for implantation within a subject is provided, the pacemaker including a housing, at least one sensor configured to detect an activity level of the subject, and at least one processor coupled to the sensor configured to detect inactivity of the subject based on output from the at least one sensor, produce a first signal configured to increase the heart rate of the subject to a first heart rate during a first time period, wherein the first heart rate is above a resting heart rate and below 100 beats per minute, and in response to determining that the first time period has elapsed, producing a second signal configured to increase the heart rate of the subject to a second heart rate during a second time period, wherein the second heart rate is between 100 and 140 beats per minute.Type: GrantFiled: October 6, 2017Date of Patent: March 1, 2022Assignee: The University of Vermont and State Agricultural CollegeInventor: Markus Meyer
-
Patent number: 11260234Abstract: A pacemaker is configured to operate in an atrial synchronous ventricular pacing mode and, after expiration of a conduction check time interval, switch to an asynchronous ventricular pacing mode that includes setting a ventricular pacing interval to a base pacing rate interval. The pacemaker is further configured to determine when atrioventricular block detection criteria are satisfied during the asynchronous ventricular pacing mode and, responsive to the atrioventricular block detection criteria being satisfied, switch back to the atrial synchronous ventricular pacing mode.Type: GrantFiled: December 4, 2019Date of Patent: March 1, 2022Assignee: Medtronic, Inc.Inventors: Juliana E. Pronovici, James W. Busacker, Keelia Doyle, Vincent P. Ganion, Greggory R. Herr, Todd J. Sheldon, Vincent E. Splett
-
Patent number: 11260235Abstract: The present invention relates to a system for communicating an operational state of a neuronal stimulation apparatus to an individual, comprising: means for determining the operational state of the apparatus; means for transmitting a first neuronal stimulation signal to a neuronal stimulation means of the individual adapted to elicit a sensory percept in the cortex of the individual, wherein the first neuronal stimulation signal is indicative of the operational state of the apparatus. The present invention further relates to a method and computer program comprising the steps of: determining the operational state of the apparatus, transmitting a neuronal stimulation signal to a neuronal stimulation means of the individual adapted to elicit a sensory percept in the cortex of the individual, wherein the first neuronal stimulation signal is indicative of the determined operational state of the apparatus.Type: GrantFiled: October 25, 2019Date of Patent: March 1, 2022Assignee: CereGate GmbHInventor: Bálint Várkuti
-
External pulse generator device and affixation device for trial nerve stimulation and methods of use
Patent number: 11260236Abstract: Systems and methods for providing a trial neurostimulation to a patient for assessing suitability of a permanently implanted neurostimulation are provided herein. In one aspect, a trial neurostimulation system includes an EPG affixation device that secures the EPG to the patient when connected to a lead extending through a percutaneous incision to a target tissue location, while allowing for ready removal of the EPG for charging or bathing. In another aspect, the system includes an EPG provided with a multi-purpose connector receptacle through which the the EPG can deliver neurostimulation therapy to an implanted lead or the EPG can be charged. In yet another aspect, the EPG can include a multi-purpose connector receptacle that is alternatingly connectable with a plurality of differing connector to facilitate differing types of therapies with one or more neurostimulation devices, ground patches or various other devices, such as charging or testing devices.Type: GrantFiled: July 16, 2019Date of Patent: March 1, 2022Assignee: AXONICS, INC.Inventors: Prabodh Mathur, Dennis Schroeder, John Woock -
Patent number: 11260237Abstract: In embodiments, an external defibrillator has an electrical circuit with a special output stage for the high-voltage defibrillation pulse. The output stage includes switches that can turn on for delivering the pulse, and off during all other times. The output stage also includes a diverting resistance to divert electrical current that could leak into the patient while a capacitor is being charged. An optional detector may notify if a component is malfunctioning. An advantage can be that an external defibrillator may be created according to embodiments that uses, in its output stage, semiconductor switches instead of relays. As semiconductor switches weigh less and occupy less volume than relays, an external defibrillator according to embodiments may have less weight and volume. Especially in wearable defibrillator applications, less weight means less effort to carry and less volume means easier concealment under clothing.Type: GrantFiled: November 6, 2018Date of Patent: March 1, 2022Assignee: West Affum Holdings Corp.Inventors: Kenneth Frederick Cowan, Joseph Sullivan, Brian J. Bennett
-
Patent number: 11260238Abstract: A wearable cardioverter defibrillator (WCD) comprises a plurality of electrocardiography (ECG) electrodes and a plurality of defibrillator electrodes to contact the patient's skin when the WCD is delivering therapy to the patient, a preamplifier coupled to the ECG electrodes to obtain ECG data from the patient. a processor to receive the ECG data from the preamplifier, and a high voltage subsystem to provide a defibrillation voltage to the patient through the plurality of defibrillator electrodes in response to a shock signal received from the processor. In a first power mode of a range of power modes the preamplifier is configured to perform low-fidelity ECG acquisition and the processor is configured to perform simple arrythmia detection analysis, and in a second mode of the range of power modes the preamplifier is configured to perform high-fidelity ECG acquisition and the processor is configured to perform complex arrythmia detection analysis.Type: GrantFiled: June 26, 2019Date of Patent: March 1, 2022Assignee: West Affum Holdings Corp.Inventors: David P. Finch, Erick M. Roane, Kenneth F. Cowan, Derek J. Valleroy, Gregory T. Kavounas
-
Patent number: 11260239Abstract: Systems and method relate to administering phototherapy. A device includes a hollow structure having at least a first open end. The hollow structure includes a rotatable member, one or more coherent light generators, and, for each coherent light generator, one or more lenses or mirrors optically connected to the coherent light generator and configured to alter at least one aspect of a beam of coherent light. The device further includes a processing circuit including a processor and a memory storing instructions. The instructions, when executed by the processor, cause the processor to accept an input from an operator and generate one or more beams of coherent light according to a plurality of settings configured to produce a therapeutic effect at a targeted treatment site. Additionally, the rotatable member is configured to be rotated to direct the one or more beams of coherent light to the targeted treatment site.Type: GrantFiled: August 21, 2020Date of Patent: March 1, 2022Assignee: GlobaLaseReach, LLCInventor: Robert Nolan Hetz
-
Patent number: 11260240Abstract: An attachment apparatus for use in combination with a known low-level laser therapy device. The apparatus is attachable to the front portion of, and operable with, a low-level laser therapy device for passing coherent light past the fur of an animal patient. The apparatus has a body with a plurality of pins that can be pushed through the fur, and which transmit a low-level laser therapy light to skin of the animal. The pins are composed of material that transmits the required light wavelength to the animal's skin.Type: GrantFiled: May 28, 2019Date of Patent: March 1, 2022Inventor: Yonatan Gerlitz
-
Patent number: 11260241Abstract: A method and computer program product for suppressing the symptoms of multiple sclerosis (MS) by irradiating a subject exhibiting the symptoms with a pre-determined dose of UV-containing light from a light source and detecting a suppression of the clinical symptoms of MS. In particular, the detected suppression of the clinical symptoms is disassociated from the vitamin D production within the subject.Type: GrantFiled: September 14, 2018Date of Patent: March 1, 2022Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATIONInventors: Hector F. Deluca, Bryan R. Becklund
-
Patent number: 11260242Abstract: Methods and systems for use in treating one or more patient's sensory impairment, e.g., associated with peripheral neuropathy. An exemplary system may be configured to generate treatment information for treating sensory impairment in at least one body portion using photonic energy from a therapeutic laser based on data indicative of damage.Type: GrantFiled: August 26, 2019Date of Patent: March 1, 2022Assignee: Biolyst, LLC.Inventors: Timothy Kelm, Philip S. Walter, Robert B. Weigel, Joshua Reed
-
Patent number: 11260243Abstract: An infrared sudation device includes a support element (1) extending along a longitudinal axis (X) and a cover element (2a, 2b) of semicylindrical shape mounted on the support element (1) so as to delimit an internal volume extending in the longitudinal direction between the support element and the internal surface of the cover element. The internal surface of the cover element is covered at least in part with a heating layer (3a, 3b) able to emit far-infrared radiation in at least part of the internal volume. The infrared sudation device includes a housing of photocatalyst (4), permeable to the infrared radiation emitted, supporting a photocatalyst (5) and arranged in proximity to the internal face of the heating layer (3a, 3b) so as to allow the photocatalyst to be activated using the energy supplied by the infrared radiation emitted.Type: GrantFiled: December 13, 2016Date of Patent: March 1, 2022Assignee: Iyashi DômeInventor: Shogoro Uemura
-
Patent number: 11260244Abstract: A process for treating highly localized carcinoma cells that provides precise positioning of a therapeutic source of highly ionizing but weakly penetrating radiation, which can be shaped so that it irradiates essentially only the volume of the tumor. The intensity and duration of the radiation produced by the source can be activated and deactivated by controlling the neutron flux generated by an array of electrically controlled neutron generators positioned outside the body being treated. The energy of the neutrons that interact with the source element can be adjusted to optimize the reaction rate of the ionized radiation production by utilizing neutron moderating material between the neutron generator array and the body. The source device may be left in place and reactivated as needed to ensure the tumor is eradicated without exposing the patient to any additional radiation between treatments. The source device may be removed once treatment is completed.Type: GrantFiled: February 20, 2020Date of Patent: March 1, 2022Assignee: Westinghouse Electric Company LLCInventors: John H. Nelson, Michael D. Heibel
-
Patent number: 11260245Abstract: Systems and methods are provided for radiation delivery. An exemplary method includes receiving an image depicting anatomical data of a target region of patient tissue and determining an initial prescribed dose of radiotherapeutic radiation to be delivered to the target region. The method also includes discretizing the arc for VMAT into a plurality of arc segments and performing an iteration process for determining an arc dose according to radiation delivered in the arc segments. The method further includes determining whether a condition for terminating the iteration process is met and terminating the iteration process based on a result of the determination that the condition for terminating the iteration process is met.Type: GrantFiled: June 3, 2019Date of Patent: March 1, 2022Assignee: ELEKTA AB (PUBL)Inventors: Charis Kontaxis, Gijsbert Herman Bol, Bas Willem Raaymakers
-
Patent number: 11260246Abstract: Apparatus and methods for controlling a radiotherapy electron beam. Exemplary embodiments provide for focusing the electron beam at different depths by altering parameters of a plurality of magnets. Exemplary embodiments can also provide for focusing the electron beam at different depths while maintaining the energy level of the electron beam at a consistent level.Type: GrantFiled: December 3, 2020Date of Patent: March 1, 2022Assignees: Board of Regents, The University of Texas System, Tel-Hashomer Medical Research Infrastructure and Services Ltd. at the Chaim Sheba Medical CenterInventors: Dirk Bartkoski, Dror Alezra, Mohammad Salehpour, Thomas Buchholz
-
Patent number: 11260247Abstract: A passive compression wave imaging system comprises an array of sensor elements arranged in a sparse array and a processor arranged to: store a plurality of samples of the output from each of the sensor elements over a sample period; derive from the stored samples a value for each of a set of image pixels; wherein for each of the image pixels the processing means is arranged to: define a plurality of different sets of weights for the elements of the sparse array; calculate a component of a pixel value from each of the sets of weights and the stored samples; and sum the components of the pixel value to produce a final pixel value.Type: GrantFiled: September 13, 2013Date of Patent: March 1, 2022Assignee: OXSONICS LIMITEDInventors: Christian Coviello, Richard Kozick, Constantin Coussios